Legal status · Canada
Is Tirzepatide legal in Canada?
Yes. Tirzepatide is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Tirzepatide in Canada at a glance
| Classification | Health Canada approved, prescription only |
|---|---|
| Health Canada approval status | Approved by Health Canada for its labeled use |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Tirzepatide profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Health Canada has approved Tirzepatide for at least one labeled indication, so a pharmaceutical-grade product exists in Canada and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Tirzepatide is
A first-in-class dual GIP and GLP-1 receptor agonist with superior weight loss and glycemic control versus GLP-1 mono-agonists.
Tirzepatide is a once-weekly dual agonist that activates both the GIP and GLP-1 receptors. In head-to-head and placebo-controlled trials it produced greater weight loss and glycemic improvement than GLP-1 mono-agonists, with roughly 21% mean body weight reduction at the 15 mg dose over 72 weeks in SURMOUNT-1.
Mechanism: Simultaneously activates GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion, reducing glucagon, delaying gastric emptying, and reducing appetite. The GIP component is thought to add complementary metabolic effects.
Regulatory history: FDA-approved (Mounjaro for T2D and, from August 2026, to reduce major cardiovascular events in T2D; Zepbound for weight management and sleep apnea)
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Tirzepatide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Tirzepatide in other countries
United States
Approved medicineFDA-approved, prescription only
Is Tirzepatide legal in the United States?United Kingdom
Approved medicineLicensed, prescription only (MHRA)
Is Tirzepatide legal in the United Kingdom?Australia
Approved medicineTGA-registered, prescription only
Is Tirzepatide legal in Australia?Frequently asked questions
Is Tirzepatide legal in Canada?
Yes. Tirzepatide is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Can I buy Tirzepatide in Canada?
Only with a prescription. Tirzepatide is classified as "Health Canada approved, prescription only" in Canada, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Tirzepatide Health Canada approved?
Yes, for its labeled indication. In Canada Tirzepatide is classified as "Health Canada approved, prescription only". For comparison, the US FDA status is: FDA-approved (Mounjaro for T2D and, from August 2026, to reduce major cardiovascular events in T2D; Zepbound for weight management and sleep apnea). Evidence level: Strong.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Tirzepatide live on its compound profile.
Tirzepatide profileThis page is general information about the regulatory status of Tirzepatide in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.